Parkway Pantai provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1974, the JCI, MSQH accredited hospital is based in Kuala Lumpur, Malaysia and has 499 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.